UK-based pharmaceutical company AstraZeneca Plc (AZN) on Thursday disclosed that it has the capacity to produce 1 billion doses of its coronavirus vaccine should it prove to be successful. The stock rose 3.5% to $55.65 in pre-market U.S. trading. The drugmak…
Read More
AstraZeneca Can Make Up To 1B Covid-19 Vaccine Doses, Signs First Supply Pacts
